The Full Wiki

Pancreatic cancer: Quiz

  
  

Question 1: Pancreatic cancer is a malignant neoplasm of the ________.
Endocrine systemLiverPancreasDigestion

Question 2: Painless ________ (yellow skin/eyes, dark urine)[6] when a cancer of the head of the pancreas (about 60% of cases) obstructs the common bile duct as it runs through the pancreas.
VomitingJaundiceDiarrheaNausea

Question 3: About 95% of exocrine pancreatic cancers are ________ (M8140/3).
Squamous cell carcinomaICD-10 Chapter II: NeoplasmsKrukenberg tumorAdenocarcinoma

Question 4: Each year in the ________, about 42,470 individuals are diagnosed with this condition and 35,240 die from the disease.
AlaskaCanadaUnited StatesPhilippines

Question 5: Surgery can be performed for palliation, if the malignancy is invading or compressing the ________ or colon.
DuodenumHuman gastrointestinal tractSmall intestineStomach

Question 6: This marked the first FDA approval of a chemotherapy drug for a non-survival ________ endpoint.
Placebo-controlled studyClinical trialMedical researchClinical trial protocol

Question 7: In patients not suitable for resection with curative intent, palliative ________ may be used to improve quality of life and gain a modest survival benefit.
AntineoplasticATC code LChemotherapyCancer immunotherapy

Question 8: Cigarette smoking has a ________ of 1.74 with regard to pancreatic cancer; a decade of non-smoking after heavy smoking is associated with a risk ratio of 1.2.
Relative riskAttributable risk percentAttributable riskOdds ratio

Question 9: Gemcitabine was approved by the United States Food and Drug Administration in 1998 after a clinical trial reported improvements in ________ in patients with advanced pancreatic cancer.
Quality of lifeBhutanGenuine progress indicatorGavin Newsom

Question 10: ________ (5FU) may also be included, however no large randomized study has shown significant survival benefit from this addition(Berlin et al.
FluorouracilCyclophosphamidePemetrexedMethotrexate
















Got something to say? Make a comment.
Your name
Your email address
Message